研究者
J-GLOBAL ID:200901043897691646
更新日: 2022年09月19日 高橋 秀実
タカハシ ヒデミ | Takahashi Hidemi
- 易感染性症候群
別冊日本臨床領域別症候群シリーズNo.32「免疫症候群(下巻)」 2000 - ワクチン接種
免疫学イラストレイティッド〔原書第5版〕(共著) 2000 - Compromised host syndrome
Medical Syndromes of Immunological Diseases(]G0002[)(筆頭) 2000 - Vaccination
Immunology (Roitt. Brostoff, Male) 2000 - ウイルス蛋白質による免疫機能の抑制:持続感染への手がかりを求めて
HIV/AIDS研究はいま(基礎研究の現場から)(筆頭) 1997 - Inhibition of immune system by viralprotein : Anew aspect for persistent infection
1997 - An immunodominant determinant of HIV-1 envelope recognized by both class-I-restricted CD8<sup>+</sup>CTL and class-II-restricted CD4<sup>+</sup> helper T cells shares similar MHC-binding sites.
Vaccine 94(Cold Spring Harbor Laboratory Press)(筆頭) 1994 - Elicitation of CD8+ class-I-restricted CTLs by immunization with irradiated HIV-1 peptide-pulsed dendritic cells.
Vaccines 93(Cold Spring Harbor Laboratory Press)(筆頭) 1993 - Analysis of CTL cross-reactivity to an HIV-1 immuuodominant determinant : Elicitation of widely cross-reactive CTLs.
Vaccine 92(Cold Spring Harbor Laboratory Press)(筆頭) 1992 - エイズウイルスに関するワクチン開発の現状
Annual Review免疫1991(筆頭) 1991 - Recent progress on HIV vaccine development
1991 - An unique Subunit immunogen (ISCOM-qp160) can elicit MHC class-I-restricted HIV envelope-specific CD8<sup>+</sup>CTL.
Vaccine 91(Cold Spring Harbor Laboratory Press)(筆頭) 1991 - Immunodominant CTL epitope of HIV-1 envelope protein : The relationship between viral mutation and CTL specificity.
Vaccine 90(Cold Spring Harbor Laboratory Press)(筆頭) 1990 - Limited epitope repertoire recognized with class I MHC molecules by murine cytotoxic T lymphocytes on the HIV qp160 envelope glycoprotein.
Vaccin 89(Cold Spring Harbor Laboratory Press)(筆頭) 1989
前のページに戻る